TECANA 20MG/ML VIAL 20 Powder for solution for infusion 5ml Vial
Product Details
TECANA 20mg/ml Powder for Solution for Infusion is a vital medication designed for intravenous administration.
Each 5ml vial contains Irinotecan Hydrochloride Trihydrate, an active ingredient widely recognized in oncology.
This product, from the trusted manufacturer SPIMACO, is typically supplied in a package containing 20 vials.
It is specifically formulated for use by healthcare professionals in a clinical setting.
Benefits of Use
TECANA (Irinotecan) is a chemotherapy agent used in the treatment of various types of cancer, including metastatic colorectal cancer.
It works by inhibiting topoisomerase I, an enzyme crucial for DNA replication, thereby preventing cancer cell growth and division.
Administered under strict medical supervision, it plays a critical role in slowing the progression of certain aggressive cancers.
The formulation ensures accurate dosing and controlled delivery of the active substance.
How to Use
- TECANA is for intravenous infusion only and must be administered by a qualified healthcare professional.
- The recommended dose and schedule depend on the specific cancer, patient's condition, prior treatments, and other medical factors, determined by the treating physician.
- The powder in the vial must be reconstituted with an appropriate diluent, and then further diluted with 5% Dextrose Injection, USP, or 0.9% Sodium Chloride Injection, USP, to a final concentration before infusion.
- The infusion should be administered over a period of 30 to 90 minutes.
- Regular monitoring of blood counts and managing potential side effects are crucial during treatment.
Caution & Warnings
- Severe myelosuppression (bone marrow depression), leading to neutropenia, anemia, and thrombocytopenia, is a common and potentially life-threatening side effect.
- Severe diarrhea, both early (occurring during or shortly after infusion) and late (occurring more than 24 hours after infusion), can occur and requires prompt management.
- Nausea, vomiting, and abdominal cramping are common gastrointestinal side effects.
- Hypersensitivity reactions, including anaphylaxis, have been reported; monitor patients closely during and after administration.
- Interstitial lung disease has been observed in some patients; discontinue if new or worsening pulmonary symptoms occur.
- Avoid use during pregnancy and breastfeeding due to potential harm to the fetus or infant.
- Patients with impaired liver function or Gilbert's syndrome may be at increased risk of toxicity.
- This medication should only be prepared and administered by personnel trained in the safe handling of cytotoxic agents.
Ingredients
Active Ingredient: Irinotecan Hydrochloride Trihydrate.
Other ingredients include, but are not limited to, water for injection and various excipients to ensure stability and proper formulation.
Product Details
Form: Powder for solution for infusion.
Strength: 20mg/ml.
Vial Size: 5ml.
Package Size: 20 Vials.
Manufacturer: SPIMACO.
Therapeutic Class: Antineoplastic (Chemotherapy).
| Gtin | 6-5251-19 |
|---|---|
| Recommended Sale Price | 169.05 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | IRINOTECAN |
| SFDA Reg. No | 6-5251-19 |
| IBC | 6-5251-19 |
| Drug Type | Prescription |
| Scientific Name | Irinotecan Hydrochloride Trihydrate |
| Strength | 20mg/ml |
| Strength Unit | mg/ml |
| Form | Powder for solution for infusion |
| Admin Route | Intravenous |
| Size | 5 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 20 Vials |
| Storage conditions | Store between 2-8C. Protect from light. |
| Refrigerator Storage | Yes |
| Distribute area | Saudi Arabia |
